World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
64
Citations
17807
World Ranking
2908
National Ranking
119

Overview

Michael H. Kershaw is affiliated with the Peter MacCallum Cancer Centre in Australia and conducts research primarily in medicine, immunology and microbiology, and engineering. Their work significantly focuses on oncology, immunology, and biomedical engineering, with subfields in molecular biology and electrical and electronic engineering.

The core topics of Michael H. Kershaw's research include CAR-T cell therapy, nanowire synthesis and applications, immunotherapy and immune responses, viral infectious diseases and gene expression in insects, immune cell function and interaction, cancer immunotherapy and biomarkers, as well as advancements in semiconductor devices and circuit design.

Michael H. Kershaw has published multiple papers across several scientific journals. Notable recent publications include:

  • Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies, 2021, Journal for ImmunoTherapy of Cancer
  • T STEM -like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models, 2023, Science Translational Medicine
  • Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatment, 2020, Clinical & Translational Immunology
  • Enhancing chimeric antigen receptor T-cell immunotherapy against cancer using a nanoemulsion-based vaccine targeting cross-presenting dendritic cells, 2020, Clinical & Translational Immunology
  • Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancers, 2021, Immunotherapy Advances

The publication venues where Michael H. Kershaw frequently publishes include Clinical & Translational Immunology, Regular and Young Investigator Award Abstracts, Cancers, Journal of Thoracic Disease, and Journal for ImmunoTherapy of Cancer.

They collaborate regularly with several researchers, including Clare Y. Slaney, Phillip K. Darcy, Amanda J. Oliver, Bianca von Scheidt, and Aaron J Harrison.

Best Publications

  • Natural Innate and Adaptive Immunity to Cancer

    Matthew D. Vesely;Michael H. Kershaw;Michael H. Kershaw;Michael H. Kershaw;Robert D. Schreiber;Mark J. Smyth;Mark J. Smyth

  • A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer

    Michael H. Kershaw;Michael H. Kershaw;Michael H. Kershaw;Jennifer A. Westwood;Jennifer A. Westwood;Linda L. Parker;Gang Wang;Gang Wang

  • Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells

    Liza B John;Christel Devaud;Connie P M Duong;Carmen S M Yong

  • Gene-engineered T cells for cancer therapy

    Michael H Kershaw;Jennifer A Westwood;Phillip K Darcy;Phillip K Darcy

  • Activating and inhibitory receptors of natural killer cells.

    Hollie J Pegram;Daniel M Andrews;Mark J Smyth;Phillip K Darcy

  • Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia.

    David S. Ritchie;Paul J. Neeson;Paul J. Neeson;Amit Khot;Stefan Peinert

  • Cytokines in cancer immunity and immunotherapy

    Mark J. Smyth;Erika Cretney;Michael H. Kershaw;Yoshihiro Hayakawa

  • Trafficking of T Cells into Tumors

    Clare Y. Slaney;Clare Y. Slaney;Michael H. Kershaw;Phillip K. Darcy

  • Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking.

    Yuekang Xu;Yuekang Xu;Yifan Zhan;Andrew M. Lew;Shalin H. Naik;Shalin H. Naik

  • Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2.

    Michael H. Kershaw;Gang Wang;Jennifer A. Westwood;Russell K. Pachynski

  • Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity.

    A J Davenport;R S Cross;R S Cross;K A Watson;Y Liao

  • Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses

    Paul A. Beavis;Paul A. Beavis;Nicole Milenkovski;Nicole Milenkovski;Melissa A. Henderson;Melissa A. Henderson;Liza B. John;Liza B. John

  • A network of PDZ-containing proteins regulates T cell polarity and morphology during migration and immunological synapse formation.

    Mandy J. Ludford-Menting;Jane Oliaro;Faruk Sacirbegovic;Eric T.-Y. Cheah

  • Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy

    Paul A. Beavis;Paul A. Beavis;Melissa A. Henderson;Melissa A. Henderson;Lauren Giuffrida;Lauren Giuffrida;Jane K. Mills;Jane K. Mills

  • CARs versus BiTEs: A Comparison between T Cell–Redirection Strategies for Cancer Treatment

    Clare Y Slaney;Pin Wang;Phillip K Darcy;Phillip K Darcy;Michael H Kershaw;Michael H Kershaw

  • Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

    Christel Devaud;Liza B John;Jennifer A Westwood;Phillip K Darcy

  • Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors

    Nicole M Haynes;Joseph A Trapani;Michèle W L Teng;Jacob T Jackson

  • CAR T-cell therapy of solid tumors.

    Carmen S M Yong;Valerie Dardalhon;Christel Devaud;Naomi Taylor

  • Autoimmunity associated with immunotherapy of cancer.

    Sally M. Amos;Connie P. M. Duong;Jennifer A. Westwood;David S. Ritchie

  • Supernatural T cells: genetic modification of T cells for cancer therapy

    Michael H. Kershaw;Michele W. L. Teng;Mark J. Smyth;Phillip K. Darcy

Frequent Co-Authors

Phillip K. Darcy
Phillip K. Darcy Peter MacCallum Cancer Centre
Mark J. Smyth
Mark J. Smyth QIMR Berghofer Medical Research Institute
Joseph A. Trapani
Joseph A. Trapani Peter MacCallum Cancer Centre
Paul A. Beavis
Paul A. Beavis Peter MacCallum Cancer Centre
Michele W. L. Teng
Michele W. L. Teng QIMR Berghofer Medical Research Institute
David Ritchie
David Ritchie Peter MacCallum Cancer Centre
Sherene Loi
Sherene Loi Peter MacCallum Cancer Centre
H. Miles Prince
H. Miles Prince Peter MacCallum Cancer Centre
Andrew M. Scott
Andrew M. Scott La Trobe University
Ricky W. Johnstone
Ricky W. Johnstone Peter MacCallum Cancer Centre

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare careers where understanding the immune system is crucial. For those interested in fast-tracking into nursing, exploring the easiest absn programs to get into can provide a quick pathway to becoming a registered nurse with a strong foundation in immunological principles applied in clinical settings.

Entry-level opportunities are also available through the easiest lpn programs to get into, ideal for students aiming for practical nursing roles that often involve patient care relating to immune health and infectious diseases.

For advanced practice, the easiest np programs to get into offer pathways to become nurse practitioners who play a key role in immunology-related healthcare services, including disease prevention and immunization management.

Specialized fields such as mental health nursing also intersect with immunology. The best psychiatric mental health nurse practitioner programs online provide excellent clinical training opportunities for those interested in how immune function can influence psychiatric conditions.

Best Scientists Citing Michael H. Kershaw

Trending Scientists

Recently Published Articles